CLX-MET-101

N/A

Report date: 2023/02/21 16:48:50

Base Information

Drug NameCLX-MET-101

Drug Alias NameMSTM-102CLX-MET-101MSTM-101

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGluconeogenesis inhibitorsAMP-activated protein kinases activators

TargetsAMP-activated protein kinases

Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellix Bio Pvt Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Inactive IndicationsN/A

ATC CodeN/A